Jixun Lin
Fondateur chez ADICON HOLDINGS LIMITED
Fortune : 134 M $ au 30/04/2024
Profil
Jixun Lin is the founder of ACON Laboratories, Inc. (founded in 1995) and ADICON Holdings Ltd.
(founded in 2004).
He is currently a Director at ACEA Therapeutics, Inc. Dr. Lin previously served as Chairman at ACEA Biosciences, Inc. and as an Independent Director at Mindray Medical International Ltd.
(from 2012 to 2016).
He holds a doctorate degree from the University of South Carolina (conferred in 1995) and an undergraduate degree from Zhejiang University (conferred in 1987).
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ADICON HOLDINGS LIMITED
12,38% | 30/06/2023 | 90 061 994 ( 12,38% ) | 134 M $ | 30/04/2024 |
Postes actifs de Jixun Lin
Sociétés | Poste | Début |
---|---|---|
ADICON HOLDINGS LIMITED | Fondateur | 01/01/2004 |
ACON Laboratories, Inc.
ACON Laboratories, Inc. Medical SpecialtiesHealth Technology ACON Laboratories, Inc. develops pharmaceutical products. It provides diagnostic testing kits for consumers, physicians, and medical researchers. The company was founded in 1996 and is headquartered in San Diego, CA. | Fondateur | 01/01/1995 |
ACEA Therapeutics, Inc.
ACEA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acea Therapeutics, Inc. provides health care services. It specializes in lung cancer, lupus and lymphoma treatments. The company was founded by Xiao Xu and Xiaobo Wang is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jixun Lin
Sociétés | Poste | Fin |
---|---|---|
MINDRAY MEDICAL INTERNATIONAL LTD (ADR) | Directeur Financier/CFO | 23/04/2012 |
ACEA Biosciences, Inc.
ACEA Biosciences, Inc. BiotechnologyHealth Technology ACEA Biosciences, Inc. develops bio-sensor platform based on microelectronic technologies. The firm pioneers in development and commercialization of innovative cell analysis instrumentation for life sciences, and is also engaged in drug discovery and pharmaceutical development. Its xCELLigence impedance-based, label-free, real-time cell analysis systems and NovoCyte benchtop flow cytometers are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research. The company was founded in 2002 and is headquartered in San Diego, CA. | Président | - |
Formation de Jixun Lin
University of South Carolina | Doctorate Degree |
Zhejiang University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ADICON HOLDINGS LIMITED | Health Services |
Entreprise privées | 4 |
---|---|
ACON Laboratories, Inc.
ACON Laboratories, Inc. Medical SpecialtiesHealth Technology ACON Laboratories, Inc. develops pharmaceutical products. It provides diagnostic testing kits for consumers, physicians, and medical researchers. The company was founded in 1996 and is headquartered in San Diego, CA. | Health Technology |
Mindray Medical International Ltd.
Mindray Medical International Ltd. Medical SpecialtiesHealth Technology Mindray Medical International Ltd. is a holding company that engages in the development, manufacture, and distribution of medical devices. Its products include orthopedic and endoscopic devices and healthcare information technology solutions. The company operates through the following segments: Patient Monitoring and Life Support, In-vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Supports Products segments includes patient monitoring devices which tracks the physiological parameters of patients such as heart rate, blood pressure, respiration and temperature for adult, pediatric, and neonatal patients for hospital intensive care units, operating rooms, and emergency rooms; and the life support products are to provide operation room or intensive care unit solutions for the end-users in the operating room. Its products include single- and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that can collect and display multiple patient data on a single screen, and an electro-cardiogram monitoring devices for patient monitoring devices, and anesthesia machines, defibrillators, surgical beds, surgical lights ceiling pendants, syringes, and infusion pumps, and ventilators for the life supports products. The In-vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples. It offers hematology, biochemistry, urine sediment, microbiology, and coagulation analyzers, and reagents. The Medical Imaging Systems segment includes ultrasound, digital radiography, and magnetic resonance imaging systems. The company was founded by Xu Hang and Li Xi Ting on June 10, 2005 and is headquartered in Shenzhen, China. | Health Technology |
ACEA Biosciences, Inc.
ACEA Biosciences, Inc. BiotechnologyHealth Technology ACEA Biosciences, Inc. develops bio-sensor platform based on microelectronic technologies. The firm pioneers in development and commercialization of innovative cell analysis instrumentation for life sciences, and is also engaged in drug discovery and pharmaceutical development. Its xCELLigence impedance-based, label-free, real-time cell analysis systems and NovoCyte benchtop flow cytometers are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research. The company was founded in 2002 and is headquartered in San Diego, CA. | Health Technology |
ACEA Therapeutics, Inc.
ACEA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acea Therapeutics, Inc. provides health care services. It specializes in lung cancer, lupus and lymphoma treatments. The company was founded by Xiao Xu and Xiaobo Wang is headquartered in San Diego, CA. | Health Technology |